Stock Chart

SRRK

$41.37 -1.41%
Score: 71.6 HOLD
LEAPs: SELL $60
i
LEAPs Option Signal

Type: SELL wallstreet
Strike: $60
Premium: $8.61
Expiry: Jan 15, 2027
Target: $55
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 0.39x (vs SPY: 0.7x | vs QQQ: 0.6x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 23, 2026
Bear Pennant Bearish scenario quality 61/100
Setup invalidates on a close above $42.97 · pole −23% — no price target (measured-move targets failed our backtest for flags/pennants)
Historically breaks down 70% of the time (n=1,730). Measured-move targets failed our backtest — none shown.
Pattern detection is automated and probabilistic — a scenario map for levels, not a buy/sell signal. Rails, projected path and invalidation level are drawn on the chart below.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About SRRK - Scholar Rock Holding Corporation Common Stock

Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.

Key Statistics

Market Cap $5B

This SRRK stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track SRRK's price movements with trendlines, gamma walls, and key support/resistance levels.